The trial will assess Precem-TcT, both as monotherapy and in combination with bevacizumab, in patients whose disease has progressed after or become resistant to standard treatments
Clears major obesity endpoints at 80 weeks
The approval was granted by Agenzia Italiana del Farmaco
The new CRS offering is delivered from WACKER’s Biotechnology Center in Munich
Diagnostic-guided healthcare platform strengthens leadership team to accelerate AI-driven diagnostics and consumer healthcare expansion
Organizations that embrace it thoughtfully today will help shape a healthier tomorrow, for India and beyond
SERB has a substantial European commercial presence and a successful track record in critical care and rare disease commercialization
By leveraging digital screening and remote consultation, the medical community is moving beyond the confines of the clinic
Collaboration with Siddhi Diagnostics combines genomics and advanced imaging capabilities to strengthen precision diagnostics in high-growth suburban markets
Subscribe To Our Newsletter & Stay Updated
